179 related articles for article (PubMed ID: 31995621)
21. Integrated Molecular and Clinical Analysis of 1,000 Pediatric Low-Grade Gliomas.
Ryall S; Zapotocky M; Fukuoka K; Nobre L; Guerreiro Stucklin A; Bennett J; Siddaway R; Li C; Pajovic S; Arnoldo A; Kowalski PE; Johnson M; Sheth J; Lassaletta A; Tatevossian RG; Orisme W; Qaddoumi I; Surrey LF; Li MM; Waanders AJ; Gilheeney S; Rosenblum M; Bale T; Tsang DS; Laperriere N; Kulkarni A; Ibrahim GM; Drake J; Dirks P; Taylor MD; Rutka JT; Laughlin S; Shroff M; Shago M; Hazrati LN; D'Arcy C; Ramaswamy V; Bartels U; Huang A; Bouffet E; Karajannis MA; Santi M; Ellison DW; Tabori U; Hawkins C
Cancer Cell; 2020 Apr; 37(4):569-583.e5. PubMed ID: 32289278
[TBL] [Abstract][Full Text] [Related]
22. Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy.
Kline CN; Joseph NM; Grenert JP; van Ziffle J; Talevich E; Onodera C; Aboian M; Cha S; Raleigh DR; Braunstein S; Torkildson J; Samuel D; Bloomer M; Campomanes AGA; Banerjee A; Butowski N; Raffel C; Tihan T; Bollen AW; Phillips JJ; Korn WM; Yeh I; Bastian BC; Gupta N; Mueller S; Perry A; Nicolaides T; Solomon DA
Neuro Oncol; 2017 May; 19(5):699-709. PubMed ID: 28453743
[TBL] [Abstract][Full Text] [Related]
23. Targeted detection of genetic alterations reveal the prognostic impact of H3K27M and MAPK pathway aberrations in paediatric thalamic glioma.
Ryall S; Krishnatry R; Arnoldo A; Buczkowicz P; Mistry M; Siddaway R; Ling C; Pajovic S; Yu M; Rubin JB; Hukin J; Steinbok P; Bartels U; Bouffet E; Tabori U; Hawkins C
Acta Neuropathol Commun; 2016 Aug; 4(1):93. PubMed ID: 27577993
[TBL] [Abstract][Full Text] [Related]
24. Exploiting molecular biology for diagnosis and targeted management of pediatric low-grade gliomas.
Garcia MA; Solomon DA; Haas-Kogan DA
Future Oncol; 2016 Jun; 12(12):1493-506. PubMed ID: 27072750
[TBL] [Abstract][Full Text] [Related]
25. Retrospective and integrative analyses of molecular characteristics and their specific imaging parameters in pediatric grade 1 gliomas.
Coutant M; Lhermitte B; Guérin E; Chammas A; Reita D; Sebastia C; Douzal V; Gabor F; Salmon A; Chenard MP; Todeschi J; Coca A; Heng MA; Vincent F; Entz-Werlé N
Pediatr Blood Cancer; 2022 Aug; 69(8):e29575. PubMed ID: 35373885
[TBL] [Abstract][Full Text] [Related]
26. Genomic and epigenomic re-categorization of congenital glioblastoma and desmoplastic infantile ganglioglioma.
Gilani A; Siddiq Z; Kissell E; Kasson J; Kleinschmidt-DeMasters BK
Childs Nerv Syst; 2023 Jul; 39(7):1861-1868. PubMed ID: 36707425
[TBL] [Abstract][Full Text] [Related]
27. Impact of gross total resection in patients with WHO grade III glioma harboring the IDH 1/2 mutation without the 1p/19q co-deletion.
Kawaguchi T; Sonoda Y; Shibahara I; Saito R; Kanamori M; Kumabe T; Tominaga T
J Neurooncol; 2016 Sep; 129(3):505-514. PubMed ID: 27401154
[TBL] [Abstract][Full Text] [Related]
28. Early experience with formalin-fixed paraffin-embedded (FFPE) based commercial clinical genomic profiling of gliomas-robust and informative with caveats.
Movassaghi M; Shabihkhani M; Hojat SA; Williams RR; Chung LK; Im K; Lucey GM; Wei B; Mareninov S; Wang MW; Ng DW; Tashjian RS; Magaki S; Perez-Rosendahl M; Yang I; Khanlou N; Vinters HV; Liau LM; Nghiemphu PL; Lai A; Cloughesy TF; Yong WH
Exp Mol Pathol; 2017 Aug; 103(1):87-93. PubMed ID: 28663030
[TBL] [Abstract][Full Text] [Related]
29. Clinical and molecular characteristics of pediatric low-grade glioma complicated with ventriculo-peritoneal shunt related ascites.
Solano-Páez P; Fonseca A; Baroni LV; Amayiri N; Somarriba MP; Freytes C; Quiroga E; Rivero M; Márquez J; Lassaletta Á; Bouffet E
J Neurooncol; 2022 Mar; 157(1):147-156. PubMed ID: 35122583
[TBL] [Abstract][Full Text] [Related]
30. Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology.
Qaddoumi I; Orisme W; Wen J; Santiago T; Gupta K; Dalton JD; Tang B; Haupfear K; Punchihewa C; Easton J; Mulder H; Boggs K; Shao Y; Rusch M; Becksfort J; Gupta P; Wang S; Lee RP; Brat D; Peter Collins V; Dahiya S; George D; Konomos W; Kurian KM; McFadden K; Serafini LN; Nickols H; Perry A; Shurtleff S; Gajjar A; Boop FA; Klimo PD; Mardis ER; Wilson RK; Baker SJ; Zhang J; Wu G; Downing JR; Tatevossian RG; Ellison DW
Acta Neuropathol; 2016 Jun; 131(6):833-45. PubMed ID: 26810070
[TBL] [Abstract][Full Text] [Related]
31. Surgical and molecular considerations in the treatment of pediatric thalamopeduncular tumors.
Lee RP; Foster KA; Lillard JC; Klimo P; Ellison DW; Orr B; Boop FA
J Neurosurg Pediatr; 2017 Sep; 20(3):247-255. PubMed ID: 28686121
[TBL] [Abstract][Full Text] [Related]
32. BRAF Status in Personalizing Treatment Approaches for Pediatric Gliomas.
Olow A; Mueller S; Yang X; Hashizume R; Meyerowitz J; Weiss W; Resnick AC; Waanders AJ; Stalpers LJ; Berger MS; Gupta N; James CD; Petritsch CK; Haas-Kogan DA
Clin Cancer Res; 2016 Nov; 22(21):5312-5321. PubMed ID: 27217440
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathological analysis of BRAF and non-BRAF MAPK pathway-altered gliomas in paediatric and adult patients: a single-institution study of 40 patients.
Ali RH; Almanabri M; Ali NY; Alsaber AR; Khalifa NM; Hussein R; Alateeqi M; Mohammed EMA; Jama H; Almarzooq A; Benobaid N; Alqallaf Z; Ahmed AA; Bahzad S; Almurshed M
J Clin Pathol; 2024 Jan; ():. PubMed ID: 38195220
[TBL] [Abstract][Full Text] [Related]
34. The Changing Landscape of Pediatric Low-Grade Gliomas: Clinical Challenges and Emerging Therapies.
Guerreiro Stucklin AS; Tabori U; Grotzer MA
Neuropediatrics; 2016 Apr; 47(2):70-83. PubMed ID: 26764564
[TBL] [Abstract][Full Text] [Related]
35. Pediatric low-grade glioma: Targeted therapeutics and clinical trials in the molecular era.
Manoharan N; Liu KX; Mueller S; Haas-Kogan DA; Bandopadhayay P
Neoplasia; 2023 Feb; 36():100857. PubMed ID: 36566593
[TBL] [Abstract][Full Text] [Related]
36. Clinical utility and treatment outcome of comprehensive genomic profiling in high grade glioma patients.
Blumenthal DT; Dvir A; Lossos A; Tzuk-Shina T; Lior T; Limon D; Yust-Katz S; Lokiec A; Ram Z; Ross JS; Ali SM; Yair R; Soussan-Gutman L; Bokstein F
J Neurooncol; 2016 Oct; 130(1):211-219. PubMed ID: 27531351
[TBL] [Abstract][Full Text] [Related]
37. Pediatric brain tumors: genetics and clinical outcome.
Faria C; Miguéns J; Antunes JL; Salgado D; Nunes S; Barroso C; Martins Mdo C; Nunes VM; Roque L
J Neurosurg Pediatr; 2010 Mar; 5(3):263-70. PubMed ID: 20192643
[TBL] [Abstract][Full Text] [Related]
38. Characterizing temporal genomic heterogeneity in pediatric high-grade gliomas.
Salloum R; McConechy MK; Mikael LG; Fuller C; Drissi R; DeWire M; Nikbakht H; De Jay N; Yang X; Boue D; Chow LML; Finlay JL; Gayden T; Karamchandani J; Hummel TR; Olshefski R; Osorio DS; Stevenson C; Kleinman CL; Majewski J; Fouladi M; Jabado N
Acta Neuropathol Commun; 2017 Oct; 5(1):78. PubMed ID: 29084603
[TBL] [Abstract][Full Text] [Related]
39. Tectal glioma as a distinct diagnostic entity: a comprehensive clinical, imaging, histologic and molecular analysis.
Liu APY; Harreld JH; Jacola LM; Gero M; Acharya S; Ghazwani Y; Wu S; Li X; Klimo P; Gajjar A; Chiang J; Qaddoumi I
Acta Neuropathol Commun; 2018 Sep; 6(1):101. PubMed ID: 30253793
[TBL] [Abstract][Full Text] [Related]
40. Molecular genetics of ependymomas and pediatric diffuse gliomas: a short review.
Nobusawa S; Hirato J; Yokoo H
Brain Tumor Pathol; 2014 Oct; 31(4):229-33. PubMed ID: 25182241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
